Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00097175 · ClinicalTrials.gov registry record

Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
95
Enrollment target

NCT00097175: Completed study, sponsored by National Institute of Mental Health (NIMH).

NCT00097175 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00097175 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
95 participants
Enrollment target

Study Summary

This study will investigate how the brain process emotions in healthy people and in patients who have major depression in order to better understand the causes of depression. It will examine what happens in the brain when a person responds to words related to different emotions while the brain's ability to manufacture a chemical called serotonin is reduced. Serotonin regulates functions such as emotion, anxiety and sleep, and stress hormones such as cortisol. In this study, participants' serotonin levels are reduced by depleting tryptophan, an amino acid that is the main building block for serotonin. Healthy volunteers and patients with major depression that has been in remission for at least 3 months may be eligible for this study. Candidates must be between 18 and 50 years of age and right-handed. They are interviewed about their medical and psychiatric history, current emotional state and sleep pattern, and family history of psychiatric disorders. Screening also includes psychiatric interviews and rating scales, neuropsychological tests, physical examination, electrocardiogram (EKG), and blood, urine, and saliva tests. Women have their menstrual phase determined by a blood test and home urine ovulation test kit. The study involves two clinic visits in which participants undergo tryptophan depletion and magnetic resonance imaging (MRI). Subjects arrive at the NIH Clinical Center in the morning after fasting overnight. They fill out questionnaires have a blood sample drawn, and then take 74 capsules that contain a mixture of amino acids found in the diet. At one visit they are given capsules that contain a balanced mixture of amino acids one would normally eat in a day; at the other visit, some of the capsules contain lactose instead of tryptophan, causing tryptophan depletion. At 2 p.m. participants fill out the same questionnaires they completed at the beginning of the day and have another blood sample drawn. Then they do a computerized test in the MRI scanner.

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2004-11-10
Est. Completion 2014-01-15

What the finished NCT00097175 record still lists

NCT00097175 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 95 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00097175 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00097175 about?

NCT00097175 is a clinical study titled "Effects of Tryptophan Depletion on Brain Processing of Emotions in Patients With Mood Disorders". This study will investigate how the brain process emotions in healthy people and in patients who have major depression in order to better understand the causes of depression. It will examine what happens in the brain when a person responds to words related to different emotions while the brain's abi...

What is the current status of trial NCT00097175?

This trial is currently completed. The enrollment target is 95 participants. The study started on 2004-11-10. Estimated completion is 2014-01-15.

Who is sponsoring clinical trial NCT00097175?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00097175, the US trial registry maintained by the National Library of Medicine. NCT00097175 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.